Patents by Inventor Abhisek Banerjee

Abhisek Banerjee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
    Publication number: 20250230144
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Application
    Filed: April 7, 2025
    Publication date: July 17, 2025
    Inventors: James A. Johnson, John Lloyd, Heather Finlay, James Neels, Naveen Kumar Dhondi, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • KIF18A inhibitors
    Patent number: 12054476
    Abstract: Compounds of formula (I): as defined herein, and synthetic intermediates thereof, which are capable of modulating KIF18A protein thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of KIF18A.
    Type: Grant
    Filed: December 14, 2021
    Date of Patent: August 6, 2024
    Assignee: AMGEN INC.
    Inventors: Nuria A. Tamayo, Abhisek Banerjee, James Alexander Brown, Michael J Frohn, Jian Jeffrey Chen, Kexue Li, Qingyian Liu, Jonathan Dante Low, Vu Ma, Liping H. Pettus, Mary Catherine Walton, Ana Elena Minatti, Matthew Paul Bourbeau, Lei Jia
  • QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
    Publication number: 20230322726
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Application
    Filed: March 24, 2023
    Publication date: October 12, 2023
    Inventors: James A. Johnson, John Lloyd, Heather Finlay, James Neels, Naveen Kumar Dhondi, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • N-cyano-7-azanorbornane derivatives and uses thereof
    Patent number: 11572374
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: February 7, 2023
    Assignee: AMGEN INC.
    Inventors: John R. Butler, Daniel Erlanson, Russell Graceffa, Jeffrey Iwig, Joon Won Jeong, Ryan D. White, Yongwei Wu, Shuyan Yi, Xiao Mei Zheng, Jesse M. McFarland, Abhisek Banerjee
  • QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
    Publication number: 20220324836
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 13, 2022
    Inventors: James A. Johnson, John Lloyd, Heather Finlay, James Neels, Naveen Kumar Dhondi, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • KIF18A inhibitors
    Patent number: 11236069
    Abstract: Compounds of formula (I): as defined herein, and synthetic intermediates thereof, which are capable of modulating KIF18A protein thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of KIF18A.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: February 1, 2022
    Assignee: AMGEN INC.
    Inventors: Nuria A. Tamayo, Abhisek Banerjee, Jian Jeffrey Chen, Jonathan Dante Low, Ana Elena Minatti, Matthew Paul Bourbeau
  • Quinazolines as potassium ion channel inhibitors
    Patent number: 11008306
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: May 18, 2021
    Assignee: Bristol-Myers Squibb Company
    Inventors: James A. Johnson, John Lloyd, Heather Finlay, James Neels, Naveen Kumar Dhondi, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
    Publication number: 20200255407
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Application
    Filed: May 1, 2020
    Publication date: August 13, 2020
    Inventors: James A. Johnson, John Lloyd, Heather Finlay, James Neels, Naveen Kumar Dhondi, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • Quinazolines as potassium ion channel inhibitors
    Patent number: 10676460
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: June 9, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: James A. Johnson, John Lloyd, Heather Finlay, James Neels, Naveen Kumar Dhondi, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
    Publication number: 20190144426
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Application
    Filed: January 9, 2019
    Publication date: May 16, 2019
    Inventors: James A. Johnson, John Lloyd, Heather Finlay, James Neels, Naveen Kumar Dhondi, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
    Patent number: 10227340
    Abstract: Compounds having the following formula: or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C—R7, are useful as kinase modulators, including IRAK-4 modulation.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: March 12, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: Venkatram Reddy Paidi, Sreekantha Ratna Kumar, Abhisek Banerjee, Ramesh Kumar Sistla, Satheesh Kesavan Nair, William J. Pitts, John Hynes
  • Quinazolines as potassium ion channel inhibitors
    Patent number: 10214511
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: February 26, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: John Lloyd, Heather Finlay, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • THIAZOLYL- OR THIADIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS
    Publication number: 20180072712
    Abstract: Compounds having the following formula: or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C—R7, are useful as kinase modulators, including IRAK-4 modulation.
    Type: Application
    Filed: November 21, 2017
    Publication date: March 15, 2018
    Inventors: Venkatram Reddy Paidi, Sreekantha Ratna Kumar, Abhisek Banerjee, Ramesh Sistla, Satheesh Kesavan Nair, William J. Pitts, John Hynes
  • QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
    Publication number: 20180030034
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Application
    Filed: October 4, 2017
    Publication date: February 1, 2018
    Inventors: John Lloyd, Heather Finlay, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
    Patent number: 9862715
    Abstract: Compounds having the following formula: or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C—R7, are useful as kinase modulators, including IRAK-4 modulation.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: January 9, 2018
    Assignee: Bristol-Myers Squibb Company
    Inventors: Venkatram Reddy Paidi, Sreekantha Ratna Kumar, Abhisek Banerjee, Ramesh Sistla, Satheesh Kesavan Nair, William J. Pitts, John Hynes
  • System and method for ensuring code quality compliance for various database management systems
    Patent number: 9836487
    Abstract: A system and computer-implemented method for ensuring code quality compliance for one or more Database Management Systems (DBMSs) is provided. The system comprises a user interface configured to prompt one or more users to select one or more options and provide information for configuring rules corresponding to coding standards and best practices. The system further comprises a rules registration module to register the configured rules in a repository for validation. Furthermore, the system comprises a source selector to provide options to the one or more users to select one or more DBMSs and a source manager to fetch database code from the one or more selected DBMSs. In addition, the system comprises one or more parsers to parse the fetched database code, a validator to validate the parsed code using the registered rules and a report manager to provide results of the validation to the one or more users.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: December 5, 2017
    Assignee: COGNIZANT TECHNOLOGY SOLUTIONS INDIA PVT. LTD.
    Inventors: Nirmalya Ghosh, Abhisek Banerjee, Anirban Ghosh, Somenath Dhar, Subimal Nath, Mohammad Mazharuddin, Avirup Ghatak, Radhika Kallu, Sankara Iyer Srilakshmi
  • Quinazolines as potassium ion channel inhibitors
    Patent number: 9458114
    Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: October 4, 2016
    Assignee: Bristol-Myers Squibb Company
    Inventors: James A. Johnson, John Lloyd, Heather Finlay, Ji Jiang, James Neels, Naveen Kumar Dhondi, Prashantha Gunaga, Abhisek Banerjee, Ashokkumar Adisechan
  • THIAZOLYL- OR THIADIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS
    Publication number: 20160083375
    Abstract: Compounds having the following formula: or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C—R7, are useful as kinase modulators, including IRAK-4 modulation.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 24, 2016
    Inventors: VENKATRAM REDDY PAIDI, Sreekantha Ratna Kumar, Abhisek Banerjee, Ramesh Sistla, Satheesh Kesavan Nair, William J. Pitts, John Hynes
  • SYSTEM AND METHOD FOR ENSURING CODE QUALITY COMPLIANCE FOR VARIOUS DATABASE MANAGEMENT SYSTEMS
    Publication number: 20160026648
    Abstract: A system and computer-implemented method for ensuring code quality compliance for one or more Database Management Systems (DBMSs) is provided. The system comprises a user interface configured to prompt one or more users to select one or more options and provide information for configuring rules corresponding to coding standards and best practices. The system further comprises a rules registration module to register the configured rules in a repository for validation. Furthermore, the system comprises a source selector to provide options to the one or more users to select one or more DBMSs and a source manager to fetch database code from the one or more selected DBMSs. In addition, the system comprises one or more parsers to parse the fetched database code, a validator to validate the parsed code using the registered rules and a report manager to provide results of the validation to the one or more users.
    Type: Application
    Filed: November 10, 2014
    Publication date: January 28, 2016
    Inventors: Nirmalya Ghosh, Abhisek Banerjee, Anirban Ghosh, Somenath Dhar, Subimal Nath, Mohammad Mazharuddin, Avirup Ghatak, Radhika Kallu, Sankara Iyer Srilakshmi
  • Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
    Patent number: 9242976
    Abstract: Compounds having the following formula (I) or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C—R7, are useful as kinase modulators, including IRAK-4 modulation.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: January 26, 2016
    Assignee: Bristol-Myers Squibb Company
    Inventors: Venkatram Reddy Paidi, Sreekantha Ratna Kumar, Abhisek Banerjee, Ramesh Sistla, Satheesh Kesavan Nair, William J. Pitts, John Hynes